Low-grade papillary urothelial carcinoma of the urinary bladder: A clinicopathologic analysis of a post-world Health Organization/International Society of Urological Pathology classification cohort from a single academic center

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 8, 2010, Pages 1160-1163

  Miyamoto, Hiroshi ^a   Brimo, Fadi ^a   Schultz, Luciana ^a   Ye, Huihui ^a   Miller, Jeremy S ^a   Fajardo, Daniel A ^a   Lee, Thomas K ^a   Epstein, Jonathan I ^a,b   Netto, George J ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER INVASION; COHORT ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; MALE; MEDICAL SOCIETY; METASTASIS; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; SOCIETIES, MEDICAL; URINARY BLADDER NEOPLASMS; WORLD HEALTH ORGANIZATION;

EID: 77955406865     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
2. Epstein JI. The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement? Crit Rev Oncol Hematol. 2003;47(2):83-89.
3. Abel PD, Henderson D, Bennett MK, Hall RR, Williams G. Differing interpretations by pathologists of the pT category and grade of transitional cell cancer of the bladder. Br J Urol. 1988;62(4):339-342.
4. Epstein JI, Amin MB, Reuter VR, Mostofi FK for the Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol. 1998;22(12):1435-1448.
5. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. Pathology and Geneticsof Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; 2004. World Health Organization Classification of Tumours; vol 10.
6. O'Donnell MA. Advances in the management of superficial bladder cancer. Semin Oncol. 2007;34(2):85-97.
7. Soloway MS, Sofer M, Vaidya A. Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol. 2002;167(4):1573-1583.
8. Fontana D, Bellina M, Scoffone C, et al. Evaluation of c-ras oncogene product (p21) in superficial bladder cancer. Eur Urol. 1996;29(4):470-476.
9. Crew JP, O'Brien T, Bicknell R, Fuggle S, Cranston D, Harris AL. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates. J Urol. 1999;161(3):799-804.
10. Choi YD, Cho NH, Ahn HS, Cho KS, Cho SY, Yang WJ. Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma. J Urol. 2007;177(3):1174-1178.
11. Hernández S, López-Knowles E, Lloreta J, et al. Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. J Clin Oncol. 2006;24(22):3664-3671.
12. Herr HW, Donat SM, Dalbagni G. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? J Urol. 2007;177(1):75-79.
13. Holmäng S, Andius P, Hedelin H, Wester K, Busch C, Johansson SL. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol. 2001;165(4):1124-1128.
14. Desai S, Lim SD, Jimenez RE, et al. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Mod Pathol. 2000;13(12):1315-1323.
15. Oosterhuis J W A, Schapers R F M, Janssen-Heijnen M L G, Pauwels R P E, Newling DW, ten Kate F. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems. J Clin Pathol. 2002;55(12):900-905.
16. Yin H, Leong AS. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. Am J Clin Pathol. 2004;121(5):679-687.
17. Herr HW, Donat SM, Reuter VE. Management of low grade papillary bladder tumors. J Urol. 2007;178(4):1201-1205.
18. Miyamoto H, Miller JS, Fajardo DA, Lee TK, Netto GJ. Low-grade papillary urothelial carcinoma (LG-TCC) of the urinary bladder: clinicopathologic outcome analysis in a post WHO/ISUP classification single academic center cohort. Mod Pathol. 2009;2(S1): 184A.
19. Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodríguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol. 2000;163(1):73-78.
20. Holmäng S, Hedelin H, Anderstrom C, Holmberg E, Busch C, Johansson SL. Recurrence and progression in low grade papillary urothelial tumors. J Urol. 1999;162(3):702-707.
21. Ali-El-Dein B, Sarhan O, Hinev A, Ibrahiem E-HI, Nabeeh A, Ghoneim MA. Superficial bladder tumours: analysis of prognostic factors and construction of a predictive index. BJU Int. 2003;92(4):393-399.